Financial Survey Avinger and Surmodics
| SRDX Stock | USD 39.44 0.23 0.58% |
Slightly above 61% of SurModics' investor base is looking to short. The analysis of overall sentiment of trading SurModics stock suggests that many investors are alarmed at this time. SurModics' investing sentiment can be driven by a variety of factors including economic data, SurModics' earnings reports, geopolitical events, and overall market trends.
SurModics |
Avinger and Surmodics are both small-cap medical companies, but which is the better investment We will compare the two companies based on the strength of their dividends, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability. Analyst Recommendations This is a breakdown of current ratings
Read at thelincolnianonline.com
 |
SurModics Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards SurModics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
SurModics Fundamental Analysis
We analyze SurModics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SurModics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SurModics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
SurModics is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
SurModics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with SurModics stock to make a market-neutral strategy. Peer analysis of SurModics could also be used in its relative valuation, which is a method of valuing SurModics by comparing valuation metrics with similar companies.
Peers
SurModics Related Equities
| DH | Definitive Healthcare | 2.42 | ||||
| LH | Laboratory | 0.27 | ||||
| VEEV | Veeva Systems | 0.40 | ||||
| CI | Cigna Corp | 1.02 | ||||
| DOCS | Doximity | 1.10 | ||||
| MD | Mednax | 1.24 | ||||
| GH | Guardant Health | 3.58 |
Additional Tools for SurModics Stock Analysis
When running SurModics' price analysis, check to measure SurModics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SurModics is operating at the current time. Most of SurModics' value examination focuses on studying past and present price action to predict the probability of SurModics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SurModics' price. Additionally, you may evaluate how the addition of SurModics to your portfolios can decrease your overall portfolio volatility.